Is Vital Chemtech overvalued or undervalued?

As of 18 November 2025, the valuation grade for Vital Chemtech has moved from attractive to very expensive, indicating a significant shift in its market positioning. The company is currently considered overvalued based on its financial metrics. Key ratios include a PE Ratio of 30.13, an EV to EBITDA of 19.72, and a Price to Book Value of 1.47, all of which suggest a premium valuation compared to industry norms.
In comparison to its peers, Vital Chemtech's PE Ratio is notably lower than that of Solar Industries at 94.24 and Gujarat Fluoroch at 57.77, but still higher than Godrej Industries, which is rated attractive with a PE of 37.03. The company's recent stock performance has been poor, with a year-to-date return of -22.02%, significantly underperforming the Sensex's gain of 9.58% during the same period, reinforcing the notion that the stock may be overvalued in the current market context.